Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1984-02-11 to 1984-03-11
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Remarks:
Two male rats used per group. Tested doses were 500 and 5000 mg/kg bw. Environmental conditions not specified. No rationale for dose selection. No data on post-mortem examinations, clinical signs or body weights.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
no guideline available
GLP compliance:
yes
Test type:
other: Single oral gavage administration of 5000 and 500 mg/kg bw to two male rats per dose per group.
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bispropylamine
EC Number:
219-588-7
EC Name:
3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bispropylamine
Cas Number:
2469-55-8
Molecular formula:
C10H28N2OSi2
IUPAC Name:
3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bispropylamine
Test material form:
liquid
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: no data
- Stability under test conditions: no data
- Solubility and stability of the test substance in the solvent/vehicle: no data
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: no data

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: no data
- Preliminary purification step (if any): no data
- Final dilution of a dissolved solid, stock liquid or gel: the test substance was used undiluted

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Cherles River, Canada
- Females (if applicable) nulliparous and non-pregnant: not applicable
- Age at study initiation: young adult
- Weight at study initiation: 222 - 292 grams at study initiation
- Fasting period before study: no data
- Housing: individual hanging wire-mesh cages
- Diet (e.g. ad libitum): Purina Certified Rodent Chow #5002
- Water (e.g. ad libitum): no data
- Acclimation period: 30 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: dose volume not specified

DOSAGE PREPARATION (if unusual): not applicable

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: not specified
Doses:
500 and 5000 mg/kg bw
No. of animals per sex per dose:
2 males
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Every hour for the first 4 hours, then daily for 14 days. Body weight records were not reported.
- Necropsy of survivors performed: not specified
- Other examinations performed: clinical signs were not reported.
Statistics:
Not used.

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
LDLo
Effect level:
500 mg/kg bw
Based on:
test mat.
Mortality:
Both animals treated with 500 mg/kg bw/day died on day 2 post-administration. Both animals treated with 5000 mg/kg bw died within 4 hours after administration.
Clinical signs:
None reported.
Body weight:
None reported.
Gross pathology:
None reported.
Other findings:
None reported.

Applicant's summary and conclusion

Interpretation of results:
study cannot be used for classification
Conclusions:
In the acute toxicity study, conducted according to a protocol similar to OECD 423 and in compliance with GLP, the reported LDLo value was concluded to be 500 mg/kg bw.